Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 97792-45-5, Allapinin, Allapinine, Htd60494v5, Refchem:798503, 808-132-8
Molecular Formula
C32H45BrN2O8
Molecular Weight
665.6  g/mol
InChI Key
CFFYROOPXPKMEQ-IPZKEBFRSA-N
FDA UNII
HTD60494V5

Russian drug
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(1S,2S,3S,4S,5R,6S,8S,9S,10R,13S,16S,17S)-11-ethyl-3,8-dihydroxy-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl] 2-acetamidobenzoate;hydrobromide
2.1.2 InChI
InChI=1S/C32H44N2O8.BrH/c1-6-34-16-29(42-28(36)18-9-7-8-10-21(18)33-17(2)35)12-11-25(40-4)31-23(29)14-20(26(31)34)30(37)15-22(39-3)19-13-24(31)32(30,38)27(19)41-5;/h7-10,19-20,22-27,37-38H,6,11-16H2,1-5H3,(H,33,35);1H/t19-,20+,22+,23-,24+,25+,26-,27+,29-,30+,31+,32+;/m1./s1
2.1.3 InChI Key
CFFYROOPXPKMEQ-IPZKEBFRSA-N
2.2 Other Identifiers
2.2.1 UNII
HTD60494V5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Allapinin

2. Allapinine

2.3.2 Depositor-Supplied Synonyms

1. 97792-45-5

2. Allapinin

3. Allapinine

4. Htd60494v5

5. Refchem:798503

6. 808-132-8

7. Lappaconite Hydrobromide

8. (3s,6s,6as,7s,7as,8s,9r,10s,11as,12s,12ar,14s)-1-ethyl-7a,11a-dihydroxy-6,8,10-trimethoxydodecahydro-2h-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocin-3(4h)-yl 2-acetamidobenzoate Hydrobromide

9. Lappaconitine Hbr

10. Lappaconiti Hydrobromidum

11. Unii-htd60494v5

12. Allafort

13. Chembl5483031

14. Schembl30014895

15. Lappaconitine Hydrobromide [who-dd]

16. Aconitane-4,8,9-triol, 20-ethyl-1,14,16-trimethoxy-, 4-(2-(acetylamino)benzoate), Hydrobromide (1:1), (1.alpha.,14.alpha.,16.beta.)-

17. Aconitane-4,8,9-triol, 20-ethyl-1,14,16-trimethoxy-, 4-(2-(acetylamino)benzoate), Monohydrobromide, (1-alpha,14-alpha,16-beta)-

18. Aconitane-4,8,9-triol, 20-ethyl-1,14,16-trimethoxy-, 4-(2-(acetylamino)benzoate), Monohydrobromide, (1.alpha.,14.alpha.,16.beta.)-

19. Aconitane-4,8,9-triol, 20-ethyl-1,14,16-trimethyoxy-, 4-(2-(acetylamino)benzoate), Monohydrobromide, (1alpha,14alpha,16beta)-

2.4 Create Date
2015-02-20
3 Chemical and Physical Properties
Molecular Weight 665.6 g/mol
Molecular Formula C32H45BrN2O8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count8
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area127
Heavy Atom Count43
Formal Charge0
Complexity1120
Isotope Atom Count0
Defined Atom Stereocenter Count12
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Arrhythmia Agents

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.


Bronchodilator Agents

Agents that cause an increase in the expansion of a bronchus or bronchial tubes.